Heald et al. [26] compared the neurological outcomes at 1 year CA in preterm infants exposed to insulin therapy due to hyperglycemia (9 patients) or not exposed (64 patients); they used the GMDS for neurological assessment and shifted to BSID–II during the study. Here, INS is linked to Hyperglycemia.